Monthly Prescribing Reference

Evoke SCS System Approved for Chronic Intractable Pain

Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials. The Food and Drug Administration (FDA) has approved the Evoke ® Spinal ...
Healio

Q&A: Spinal cord stimulation system offers nonopioid solution to pain management

Please provide your email address to receive an email when new articles are posted on . Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic ...
Business Wire

Spinal Modulation Axium™ Spinal Cord Stimulator System (SCS) Shows Promise in Managing Chronic Pain in Difficult Pain Conditions

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...
Monthly Prescribing Reference

Senza SCS System Approval Expanded to Include Nonsurgical Refractory Back Pain

The Senza SCS System is a neuromodulation device designed to deliver electrical stimulation using implantable leads and a rechargeable, implantable pulse generator. The Food and Drug Administration ...
Business Wire

St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option

“The approval of the Proclaim Elite recharge-free SCS system is a needed advancement for both patients and physicians who now have access to a low-maintenance chronic pain treatment that can reduce ...
Nasdaq

Abbott's (ABT) Eterna SCS System Receives FDA's Approval

Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
Morningstar

New Data Show Significant Pain Relief, Reduced Opioid Use, Decreased Patient Time and Cost Burdens with the ProsperaTM SCS System

24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
Fast Company

The non-opioid solution driving the next era of pain management

In January 1999, Marianne, a nurse in Houston, Texas, was helping coworkers lift a patient when she felt a twinge in her back. At first, she believed the pain she felt was nothing more than a tweaked ...
Nasdaq

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...
Healio

FDA approves spinal cord stimulation system for chronic, nonsurgical back pain

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
The Advocate

New FDA-approved AI spine stimulator relieves 40 years of back pain for this Louisianan

Joseph Jeanmarie has had back problems since the 1980s, when he injured his back and had surgery. Although his chronic pain was sometimes debilitating, he continued his work as an insurance ...
Becker's ASC

FDA approves Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System — 4 insights

The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...